Romero GDL, Vázquez RA, del Castillo PAA

Language: Spanish
References: 9
Page: 193-196
PDF size: 79.32 Kb.

ABSTRACT

Cancer is one of the diseases that causes the highest mortality in the world, this type of treatment generates a number of side effects that, if not well treated, it’s could cause serious damage to the patient’s health. The correct handling of cytotoxic drugs is essential for patient safety; the aim is to prevent or reduce medication errors in order to improve the practice of nursing professionals. Although the recommendations for administering these drugs are very broad, the intention is to offer key points, for correct action in case of possible immediate toxicity.

REFERENCES

1. Intervenciones de Enfermería para la Seguridad en la Administración de Medicamentos de Alto Riesgo: Guía de Práctica Clínica. México, CENETEC; 2014 [21 Enero de 2020]. Disponible en: http://www.cenetec-difusion.com/CMGPC/IMSS-712-14/ER.pdf.

2. Tiziani A. Havard: fármacos en enfermería. México D.F.: Manual Moderno; 2011.

3. Coynea E, Northfieldb S, Ashc K, Brown-Westd L. Current evidence of education and safety requirements for the nursing administration of chemotherapy: an integrative review. Eur J Oncol Nurs. [Internet] 2019 [Cited 2020 September 03]; 44: 24-32. Available from: https://www-clinicalkey-es.pbidi.unam.mx:2443/service/content/pdf/watermarked/1-s2.0-S1462388919300493.pdf?locale=es_ES&searchIndex=.

4. Kohen N, Viniegra M. INC. Procedimientos básicos para la preparación, administración y desecho de drogas citostáticas. INC. [Internet] 2016 [Citado 2020 Agosto 24] Disponible en: 0000000892cnt-2016-10-11-documento-procedimiento-de-manejo-de drogas-citostáticas-2016pdf.

5. Vera R, Otero MJ, Ayala de la Peña F. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Farm Hosp [Internet] 2018 [Cited 2020 01 September]; 42 (6): 261-268. Available from: https://pubmed.ncbi.nlm.nih.gov/30298467/.

6. Otero LM. Prácticas para mejorar la seguridad de los medicamentos de alto riesgo. [Internet]. Plan de Calidad para el Sistema Nacional de Salud. 2007 [Citado 2020 Enero 27]. Disponible en: http://www.ismp-espana.org/ficheros/Practicas para mejorar la seguridad de los medicamentos de alto riesgo.pdf.

7. Blasco A, Caballero C. Toxicidad de los tratamientos oncológicos SEOM [Internet] España. [Citado 2020 Septiembre 01]. Disponible en: https://seom.org/guia-actualizada-de-tratamientos/toxicidad-de-los-tratamientos-oncologicos?showall=1.

8. Magallón Pedrera I, Pérez Altozano J, Virizuela Echaburu AJ, Beato Zambrano C. Borrega García P, de la Torre Montero JC. Safety recommendations guideline for cancer patients receiving intravenous therapy. ECO-SEOM-SEEO [Internet] 2020 [Cited 2020 August 26]. Available from: https://seom.org/images/SEOM_Safety_recommendations_guideline_cancer.pdf.

9. Sanmartína O, Beato C, Jin Suh-Ohc H, Aragón I, España A, Majemf M et al. Clinical management of cutaneous adverse events in patients on chemotherapy: a national consensus statement by the Spanish Academy of Dermatology and Venereology and The Spanish Society of Medical Oncology. Actas Demo-Sifiliograficas [Internet] 2019. [Cited 2020 Sept. 01]; 110 (6): 448-459. Available from: https://www-clinicalkey-es.pbidi.unam.mx:2443/service/content/pdf/watermarked/1-s2.0-S1578219019301507.pdf?locale=es_ES&searchIndex=.